Imricor Medical Systems, Inc. (ASX: IMR)

Market Cap	253.97M
Revenue (ttm)	1.24M
Net Income (ttm)	-30.37M
Shares Out	270.18M
EPS (ttm)	-0.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	97,383
Open	0.940
Previous Close	0.940
Day's Range	0.900 - 0.945
52-Week Range	0.410 - 0.945
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company’s principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IMR

Financial Performance

In 2023, Imricor Medical Systems's revenue was $615,568, a decrease of -24.56% compared to the previous year's $816,011. Losses were -$22.63 million, 30.4% more than in 2022.

Financial numbers in USD